BRUSSELS - A pregnancy test that could lead to a miscarriage or a child with a birth defect. Abroad, the drug Duogynon is causing controversy to this day. This autumn, a British victims' organisation is suing the manufacturer, pharmaceutical giant Schering (now Bayer).

Nobody in Belgium knows Duogynon, although the pregnancy test was also on the market here until 1978. What is more, archival documents reveal that the Belgian medicines commission did nothing for years. At Schering's request, the scandal was kept quiet. There must be victims, but how could they know?

Photo: © Tinne Claes

Team members

Tinne Claes

Tinne Claes  is a postdoctoral researcher at the University of Leuven.

€ 745 allocated on 20/03/2020.

need resources for your own investigative story?

Journalismfund Europe's flexible grants programmes enable journalists to produce relevant public interest stories with a European mind-set from international, national, and regional perspectives.


support independent cross-border investigative journalism

We rely on your support to continue the work that we do. Make a gift of any amount today.